Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip T Murphy

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|April 16, 2009
Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesisPhilip T Murphy, Suzanne McPherson, Karen Breen, et al.
Annals of Hematology|April 1, 2005
Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infectionPhilip T Murphy, Michael Fay, John Quinn, et al.
Hematology/Oncology and Stem Cell Therapy|June 29, 2016
Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusionMireille Crampe, Jennifer Garry, Stephen E Langabeer, et al.
American Journal of Hematology|February 13, 2013
A case of leptospirosis presenting as TTPDaire K Quinn, John Quinn, Peter J Conlon, et al.
Journal of Clinical Pathology|August 5, 2017
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisisStephen E Langabeer, Claire M Comerford, John Quinn, et al.
European Journal of Haematology|August 14, 2019
Wilms' tumor and preferentially expressed antigen of melanoma in patients with myeloid neoplasms treated with azacytidinePhilip T Murphy, Sinead Moran, John Quinn, et al.
Case Reports in Hematology|June 2, 2018
Protracted Clonal Trajectory of a <i>JAK2</i> V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid LeukemiaStephen E Langabeer, Karl Haslam, Maria Anne Smyth, et al.
The Annals of Pharmacotherapy|September 30, 2004
Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritisPhilip T Murphy, Michael J Fay, Ronan T Swords, et al.
International Journal of Laboratory Hematology|December 8, 2021
Cell population data from Sysmex XN analyzer and myelodysplastic syndromePhilip T Murphy, Stephen Bergin, Michelle O'Brien, et al.
Case Reports in Hematology|September 1, 2012
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular MonitoringStephen E Langabeer, Sarah L McCarron, Johanna Kelly, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|April 16, 2009
Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesisPhilip T Murphy, Suzanne McPherson, Karen Breen, et al.
Annals of Hematology|April 1, 2005
Remission of transfusion-dependent myelodysplastic syndrome in association with respiratory tract infectionPhilip T Murphy, Michael Fay, John Quinn, et al.
Hematology/Oncology and Stem Cell Therapy|June 29, 2016
Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusionMireille Crampe, Jennifer Garry, Stephen E Langabeer, et al.
American Journal of Hematology|February 13, 2013
A case of leptospirosis presenting as TTPDaire K Quinn, John Quinn, Peter J Conlon, et al.
Journal of Clinical Pathology|August 5, 2017
Molecular profiling and targeted inhibitor therapy in atypical chronic myeloid leukaemia in blast crisisStephen E Langabeer, Claire M Comerford, John Quinn, et al.
European Journal of Haematology|August 14, 2019
Wilms' tumor and preferentially expressed antigen of melanoma in patients with myeloid neoplasms treated with azacytidinePhilip T Murphy, Sinead Moran, John Quinn, et al.
Case Reports in Hematology|June 2, 2018
Protracted Clonal Trajectory of a <i>JAK2</i> V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid LeukemiaStephen E Langabeer, Karl Haslam, Maria Anne Smyth, et al.
The Annals of Pharmacotherapy|September 30, 2004
Progression of myelodysplasia during low-dose methotrexate therapy in rheumatoid arthritisPhilip T Murphy, Michael J Fay, Ronan T Swords, et al.
International Journal of Laboratory Hematology|December 8, 2021
Cell population data from Sysmex XN analyzer and myelodysplastic syndromePhilip T Murphy, Stephen Bergin, Michelle O'Brien, et al.
Case Reports in Hematology|September 1, 2012
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular MonitoringStephen E Langabeer, Sarah L McCarron, Johanna Kelly, et al.
Pageof 3